📰 Priority Bacterial Pathogens News
Priority Bacterial Pathogens News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Bacterial Pathogens. Real-time updates on events, politics, business and more.
April 22, 2024
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
April 9, 2024
Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal...
January 16, 2024
Intravacc secures $633K funding from CARB-X to develop a vaccine against or Neisseria gonorrhoeae....
January 9, 2024
/PRNewswire/ -- The Novo Nordisk Foundation is committing up to USD 25 million to support the early-stage development of innovative tools to prevent, diagnose...
October 20, 2022
/PRNewswire/ -- Day Zero Diagnostics Inc., an infectious disease diagnostics company utilizing genome sequencing and machine learning to combat the rise of...
April 20, 2022
/PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, today announced dosing of the first human subjects in its...
March 3, 2022
Investegate announcements from Spexis AG, CARB-X milestone
March 3, 2022
Spexis AG / Key word(s): Agreement/Financing Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization
March 3, 2022
Spexis AG / Key word(s): Agreement/Financing Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization
January 25, 2022
/PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, has been granted Fast Track designation by the U.S. Food and Drug...